Colorectal Cancer Clinical Trials in Arizona

Showing 41-60 of 274 trials

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

NCT05731947

This study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of revumenib in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.

Colorectal CancerSolid Tumors

Syndax Pharmaceuticals42 participantsStarted Apr 2023

Scottsdale, Arizona, United States • Boston, Massachusetts, United States • Manhattan, New York, United States +3 more locations

RECRUITINGPhase 231 miles

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

NCT06792695

The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).

Metastatic Colorectal Cancer

AstraZeneca120 participantsStarted Mar 2025

Scottsdale, Arizona, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +73 more locations

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Early Onset Colorectal Cancer Detection

EXoPERT EMERALD Clinical Study

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

A Study of MGC026 in Participants With Advanced Solid Tumors

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

A Study of PHN-010 in Patients With Advanced Solid Tumors

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Other Conditions in Arizona